Back to Authors

Singh, Charanjit

https://orcid.org/0000-0002-6906-5385

A5084701515 | I4210127938

Mayo Clinic Hospital

Citations 1

Change in 21-gene recurrence score (RS) (Oncotype DX) after exposure to neoadjuvant endocrine therapy.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e12650-e12650

10.1200/jco.2018.36.15_suppl.e12650